XML 80 R46.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Share-based Payment Arrangement, Noncash Expense [Abstract] |
Stock-based compensation | The following table summarizes stock-based compensation expense recognized during 2021, 2020 and 2019:
Year Ended December 31, | 2021 |  | 2020 |  | 2019
(Dollars in millions) |  |  |  |  |
Stock option awards | $ | 2 |  |  | $ | 3 |  |  | $ | 3 |
Restricted stock unit awards | 29 |  |  | 30 |  |  | 33 |
Performance share unit awards | 16 |  |  | 17 |  |  | 21 |
Deferred compensation bonus and matching stock unit awards | — |  |  | 1 |  |  | — |
Awards under Non-Employee Director compensation plan | 2 |  |  | 2 |  |  | 2 |
Total stock-based compensation, before income taxes | 49 |  |  | 53 |  |  | 59 |
Income tax benefit | (12) |  |  | (13) |  |  | (15) |
Total stock-based compensation expense, net of income taxes | $ | 37 |  |  | $ | 40 |  |  | $ | 44 |
Stock-based compensation, allocation by financial statement line item | The following table provides a summary of the classification of stock-based compensation expense included in the Consolidated Statement of Operations for the years ended:
December 31, | 2021 |  | 2020 |  | 2019
(Dollars in millions) |  |  |  |  |
Selling, general and administrative expense | $ | 44 |  |  | $ | 48 |  |  | $ | 54 |
Cost of services expense | 5 |  |  | 5 |  |  | 5 |
Total stock-based compensation expense | $ | 49 |  |  | $ | 53 |  |  | $ | 59 |
Stock-based compensation, fair value assumptions | TDS estimated the fair value of stock options granted in 2021, 2020 and 2019 using the Black-Scholes valuation model and the assumptions shown in the table below:
| 2021 |  | 2020 |  | 2019
Expected life | 6.3 years |  | 6.2 years |  | 6.2 years
Expected annual volatility rate | 36.6 | % |  | 35.0 | % |  | 29.0 | %
Dividend yield | 2.8 | % |  | 3.6 | % |  | 2.1 | %
Risk-free interest rate | 1.1 | % |  | 0.5 | % |  | 2.4 | %
Summary of stock options | A summary of TDS stock options (total and portion exercisable) and changes during 2021 is presented in the tables and narrative below.
Common Share Options | Number of Options |  | Weighted Average Exercise Prices |  | Aggregate Intrinsic Value (in millions) |  | Weighted Average Remaining Contractual Life (in years)
Outstanding at December 31, 2020 | 4,286,000 |  |  | $ | 25.94 |  |  |  |  |
Granted | 289,000 |  |  | $ | 25.36 |  |  |  |  |
Exercised | (23,000) |  |  | $ | 21.54 |  |  |  |  |
Forfeited | (6,000) |  |  | $ | 23.75 |  |  |  |  |
Expired | (458,000) |  |  | $ | 29.73 |  |  |  |  |
Outstanding at December 31, 2021 | 4,088,000 |  |  | $ | 25.50 |  |  | $ | — |  |  | 4.2
(3,264,000 exercisable) |  |  | $ | 25.91 |  |  | $ | — |  |  | 3.1
Summary of nonvested restricted stock units | A summary of TDS nonvested restricted stock units and changes during 2021 is presented in the table below:
Common Restricted Stock Units | Number |  | Weighted Average Grant Date Fair Value
Nonvested at December 31, 2020 | 1,496,000 |  |  | $ | 22.26 |
Granted | 580,000 |  |  | $ | 23.34 |
Vested | (451,000) |  |  | $ | 23.69 |
Forfeited | (33,000) |  |  | $ | 22.08 |
Nonvested at December 31, 2021 | 1,592,000 |  |  | $ | 22.25 |
A summary of UScellular nonvested restricted stock units and changes during 2021 is presented in the table below:
Common Restricted Stock Units | Number |  | Weighted Average Grant Date Fair Value
Nonvested at December 31, 2020 | 1,660,000 |  |  | $ | 36.43 |
Granted | 672,000 |  |  | $ | 36.68 |
Vested | (609,000) |  |  | $ | 39.10 |
Forfeited | (122,000) |  |  | $ | 35.77 |
Nonvested at December 31, 2021 | 1,601,000 |  |  | $ | 35.57 |
Summary of nonvested performance share units | A summary of TDS nonvested performance share units and changes during 2021 is presented in the table below:
Common Performance Share Units | Number |  | Weighted Average Grant Date Fair Value
Nonvested at December 31, 2020 | 924,000 |  |  | $ | 23.18 |
Granted | 303,000 |  |  | $ | 25.36 |
Vested | (152,000) |  |  | $ | 25.70 |
Change in units based on approved performance factors | 38,000 |  |  | $ | 25.70 |
Forfeited | (61,000) |  |  | $ | 24.36 |
Accumulated dividend equivalents | 33,000 |  |  | $ | 23.29 |
Nonvested at December 31, 2021 | 1,085,000 |  |  | $ | 23.46 |
A summary of UScellular’s nonvested performance share units and changes during 2021 is presented in the table below:
Common Performance Share Units | Number |  | Weighted Average Grant Date Fair Value
Nonvested at December 31, 2020 | 1,305,000 |  |  | $ | 36.60 |
Granted | 394,000 |  |  | $ | 37.67 |
Vested | (601,000) |  |  | $ | 39.50 |
Change in units based on approved performance factors | 42,000 |  |  | $ | 28.94 |
Forfeited | (91,000) |  |  | $ | 35.13 |
Nonvested at December 31, 2021 | 1,049,000 |  |  | $ | 35.17 |

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.F) -URI http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested performance-based units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration